Synonym:
(5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid,
Dinoprostone,
PGE2,
Prostaglandin E2
-
CAS Number 363-24-6
-
Empirical Formula (Hill Notation) C20H32O5
-
Molecular Weight 352.47
-
Beilstein Registry Number 4709356
-
MDL number MFCD00077861
-
PubChem Substance ID 329798733
Properties:
| Related Categories |
Analytical Standards,
Analytical/Chromatography,
EP Standards,
EP Standards C - D,
Pharmacopeia & Metrological Institutes Standards
|
Description:
Caution
Please find SDS provided by EDQM here.
.
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia
.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 60 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference subtance catalogue
.
Biochem/physiol Actions
Most biologically active prostaglandin. PGE2 induces cervical ripening and parturition; mediates bradykinin-induced vasodilation; regulates adenylyl cyclase. Tumor cells that over-express cyclooxygenase 2 display increased invasiveness, angiogenesis, and resistance to apoptosis that may be due to the PGE2-induced expression of angiogenic factors and stabilization of the anti-apoptotic protein, survivin.The effect of PGE2 on the immune system is mixed. It inhibits T cell activation in vitro, suggesting it is an immunosuppressant. However, in vivo, it appears to effect expansion of the Th17 subset and differentiation of the Th1 subset of T helper cells, marking it as an immunoactivator.
Safety:
Symbol


GHS07, GHS08
Hazard statements
H302-H360
Precautionary statements
P201-P280-P301 + P312 + P330-P308 + P313
RIDADR
NONH for all modes of transport